A 71-year-old female presented for a routine examination after breast cancer and pulmonary carcinoid tumor. She had stage II invasive ductal carcinoma of the right breast 12 years ago and was treated with right radical mastectomy and silicone prosthetic implantation. She also underwent a right-middle lobectomy for a carcinoid tumor 10 years ago. Since the removal of carcinoid tumor, no evidence of disease recurrence had been found on the preceding surveillance CT studies (Fig.1) .
. 71-year-old female with pleural silicone granuloma. Routine surveillance CT chest in soft-tissue (A) and lung (B) windows obtained several years before the current presentation demonstrated an intact silicone breast implant with no evidence of pleural or parenchymal abnormality (B).
ing for recurrence of carcinoma (Fig. 3) . No lymphadenopathy was seen on this examination. Whole-body positronemission tomography (PET) showed mild F-18 fluorodeoxyglucose (FDG) uptake in the right pleural-based nodule and the chest-wall soft-tissue mass. The avidity of FDG uptake favored a nonmalignant etiology. Biopsy of the nodule along the major fissure, performed based on the clinical suspicion of pleural metastases, revealed silicone surrounded by foreign-body granulomatous reaction and no malignant cells (Fig. 4) . The anterior chest wall mass was identified as ruptured breast implant that had formed a fistula at the previous thoracotomy site, extending into the pleural cavity. The ruptured implant and free silicone were removed from the chest wall and pleural space. A sixmonth followup showed no evidence of new pleural-based lesions.
Discussion
Pleural silicone granuloma is a rare complication of implant rupture. Most silicone granulomas have been found within the breast tissue or regional lymph nodes (1-2). Hirmund et al. first documented a patient with ruptured silicone-gel implants who developed pleural effusion containing silicone (3). Levine et al. described the first reported case of fibrothorax due to the inadvertent introduction of silicone from ruptured breast implants at the time of cardiac surgery (4). In our reported case, the patient's implant remained intact for up to 10 years after thoracotomy, eliminating the possibility that silicone was introduced into the pleural space during her previous lobectomy. The chest CT and surgical biopsy findings confirmed that the implant material had fistulised into pleural space along the prior thoracotomy scar, forming a pleural silicone granuloma along the right major fissure.
Pleural silicone granuloma can mimic pleural metastases in patients with ruptured silicone breast implants. Mild FDG uptake in these pleural lesions is attributed to surrounding granulomatous inflammation. Scars from remote thoracotomy may provide a potential pathway for ruptured silicone to fistulise into the pleural space.
